A phase 1a/b study of BR101801, a PI3K g/d and DNA PK triple inhibitor, in adult patients with advanced hematologic malignancies.
BR101801
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: A phase 1a/b study of BR101801, a PI3K g/d and DNA PK triple inhibitor, in adult patients with advanced hematologic malignancies. ### Output: BR101801